NDC | 50383-063-05, 50383-063-06, 50383-063-07, 50383-063-10, 50383-063-11, 50383-063-12, 50383-063-15, 50383-063-17, 50383-063-18 |
Set ID | 5cb704a7-301c-494e-948f-872ee0d5a289 |
Category | HUMAN OTC DRUG LABEL |
Packager | Hi-Tech Pharmacal Co., Inc. |
Generic Name | |
Product Class | |
Product Number | |
Application Number | PART341 |
- Active ingredient
- Inactive ingredients
- Purpose
- Uses
-
Warnings
Ask a doctor before use if you have
- •
- cough that occurs with too much phlegm (mucus)
- •
- cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis, or emphysema
Stop use and ask a doctor if
- •
- cough lasts more than 7 days, comes back, or is accompanied by fever, rash, or persistent headache. These could be signs of a serious condition.
- •
- you are hypersensitive to any of the ingredients
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.
Professional Note: Guaifenesin has been shown to produce a color interference with certain clinical laboratory determinations of 5-hydroxyindoleacetic acid (5-HIAA) and vanillylmandelic acid (VMA).
-
Directions
Follow dosage below or use as directed by a physician.
- •
- do not take more than 6 doses in any 24-hour period
age
dose
adults and children 12 years and over
10 to 20 mL (2 to 4 teaspoonfuls) every 4 hours
children 6 years to under 12 years
5 to 10 mL (1 to 2 teaspoonfuls) every 4 hours
children 2 to under 6 years of age
2.5 to 5 mL (1/2 to 1 teaspoonful) every 4 hours
children under 2 years of age
ask a doctor
How Supplied:
Guaifenesin Oral Solution is a clear viscous liquid with a slight cherry odor supplied in the following oral dosage forms: 5 mL unit dose, 10 mL unit dose, 15 mL unit dose in trays of 10 and 4 fl. oz. (118 mL) bottle
Phenylketonurics: contains phenylalanine 8.4 mg per teaspoonful (5 mL)
- STORAGE
- Questions or comments?
- Package/Label Principal Display Panel
-
INGREDIENTS AND APPEARANCE
GUAIFENESIN
guaifenesin solutionProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:50383-063 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN 100 mg in 5 mL Inactive Ingredients Ingredient Name Strength ACESULFAME POTASSIUM (UNII: 23OV73Q5G9) ASPARTAME (UNII: Z0H242BBR1) HYPROMELLOSE 2910 (4000 MPA.S) (UNII: RN3152OP35) MENTHOL, UNSPECIFIED FORM (UNII: L7T10EIP3A) METHYLPARABEN (UNII: A2I8C7HI9T) POTASSIUM SORBATE (UNII: 1VPU26JZZ4) WATER (UNII: 059QF0KO0R) ANHYDROUS CITRIC ACID (UNII: XF417D3PSL) Product Characteristics Color Score Shape Size Flavor CHERRY (artificial cherry flavor) , VANILLA (artificial vanilla flavor) Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:50383-063-06 4 in 1 CASE 03/07/2012 1 NDC:50383-063-05 10 in 1 TRAY 1 5 mL in 1 CUP, UNIT-DOSE; Type 0: Not a Combination Product 2 NDC:50383-063-07 10 in 1 CASE 03/07/2012 2 10 in 1 TRAY 2 5 mL in 1 CUP, UNIT-DOSE; Type 0: Not a Combination Product 3 NDC:50383-063-11 4 in 1 CASE 03/07/2012 3 NDC:50383-063-10 10 in 1 TRAY 3 10 mL in 1 CUP, UNIT-DOSE; Type 0: Not a Combination Product 4 NDC:50383-063-12 10 in 1 CASE 03/07/2012 4 10 in 1 TRAY 4 10 mL in 1 CUP, UNIT-DOSE; Type 0: Not a Combination Product 5 NDC:50383-063-17 4 in 1 CASE 03/07/2012 5 NDC:50383-063-15 10 in 1 TRAY 5 15 mL in 1 CUP, UNIT-DOSE; Type 0: Not a Combination Product 6 NDC:50383-063-18 10 in 1 CASE 03/07/2012 6 10 in 1 TRAY 6 15 mL in 1 CUP, UNIT-DOSE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part341 03/07/2012 Labeler - Hi-Tech Pharmacal Co., Inc. (117696873) Registrant - Akorn Operating Compnay LLC (117693100) Establishment Name Address ID/FEI Business Operations Hi-Tech Pharmacal Co., Inc. 117696873 MANUFACTURE(50383-063) , ANALYSIS(50383-063) , PACK(50383-063)